Form D · Biotechnology
Spinal Simplicity, LLC
Overland Park, KS · CIK 0001507286
Offering snapshot reported Jul 31, 2025 · SEC filing
- Reported sold
- $6.1M Offering amount: $10M
- Investors reported
- 27 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Dec 12, 2024 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$225,000 → $6,100,183
- Reported investors2 → 27
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 31, 2025 | Amendment | $6,100,183 | $5,875,183vs Dec 26, 2024 | 27 | SEC filing |
| Dec 26, 2024 | Initial | $225,000 | No comparison | 2 | SEC filing |
| Mar 21, 2022 | Amendment | $10,854,629 | $10,506,129vs May 25, 2021 | 80 | SEC filing |
| May 25, 2021 | Initial | $348,500 | No comparison | Not reported | SEC filing |
| Oct 28, 2014 | Initial | $250,000 | No comparison | 3 | SEC filing |
| Mar 14, 2014 | Amendment | $1,408,969 | $0vs Feb 14, 2014 | 25 | SEC filing |
| Feb 14, 2014 | Initial | $1,408,969 | No comparison | 25 | SEC filing |
| Feb 14, 2013 | Initial | $30,000 | No comparison | 1 | SEC filing |
| Dec 30, 2011 | Amendment | $2,446,187 | $1,742,587vs Dec 16, 2010 | 30 | SEC filing |
| Dec 16, 2010 | Initial | $703,600 | No comparison | 11 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-533350
Source: Form D, filed Jul 31, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Harold Hess | Executive |
| Jonathan Hess | Executive |
| Tim Mc Cown | Executive |
| Julie Mckee | Executive |
| Todd Moseley | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
6363 College Blvd Suite 320
Overland Park, KS, 66211
Overland Park, KS, 66211